List of Adocia patents

Patents where

Current Assignee

Name

Adocia

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11576952 Injectable solution at pH 7 comprising at least one basal insulin for which the pI is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals	Patent 11576952 was granted and assigned to Adocia on February, 2023 by the United States Patent and Trademark Office.	Adocia	Adocia	United States Patent and Trademark Office	11576952	February 14, 2023
‌ US Patent 9457089 Highly concentrated aqueous protein solution with reduced viscosity	Patent 9457089 was granted and assigned to Adocia on October, 2016 by the United States Patent and Trademark Office.	Adocia	Adocia	United States Patent and Trademark Office	9457089	October 4, 2016
‌ US Patent 10485851 Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid	Patent 10485851 was granted and assigned to Adocia on November, 2019 by the United States Patent and Trademark Office.	Adocia	Adocia	United States Patent and Trademark Office	10485851	November 26, 2019
‌ US Patent 8241620 Complex polymere amphiphile-PDGF	Patent 8241620 was granted and assigned to Adocia on August, 2012 by the United States Patent and Trademark Office.		Adocia	United States Patent and Trademark Office	8241620	August 14, 2012
‌ US Patent 10583175 Rapid-acting insulin formulation comprising a substituted anionic compound	Patent 10583175 was granted and assigned to Adocia on March, 2020 by the United States Patent and Trademark Office.	Adocia	Adocia	United States Patent and Trademark Office	10583175	March 10, 2020
‌ US Patent 11633460 Injectable solution at pH 7 comprising at least one basal insulin wherein the pI is comprised from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals	Patent 11633460 was granted and assigned to Adocia on April, 2023 by the United States Patent and Trademark Office.	Adocia	Adocia	United States Patent and Trademark Office	11633460	April 25, 2023
‌ US Patent 10881716 Rapid-acting insulin formulation comprising a substituted anionic compound	Patent 10881716 was granted and assigned to Adocia on January, 2021 by the United States Patent and Trademark Office.	Adocia	Adocia	United States Patent and Trademark Office	10881716	January 5, 2021
‌ US Patent 10548952 Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals	Patent 10548952 was granted and assigned to Adocia on February, 2020 by the United States Patent and Trademark Office.	Adocia	Adocia	United States Patent and Trademark Office	10548952	February 4, 2020
‌ US Patent 11129877 Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid	Patent 11129877 was granted and assigned to Adocia on September, 2021 by the United States Patent and Trademark Office.	Adocia	Adocia	United States Patent and Trademark Office	11129877	September 28, 2021
‌ US Patent 11191812 Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid	Patent 11191812 was granted and assigned to Adocia on December, 2021 by the United States Patent and Trademark Office.	Adocia	Adocia	United States Patent and Trademark Office	11191812	December 7, 2021
‌ US Patent 9492467 Rapid-acting insulin formulation comprising an oligosaccharide	Patent 9492467 was granted and assigned to Adocia on November, 2016 by the United States Patent and Trademark Office.	Adocia	Adocia	United States Patent and Trademark Office	9492467	November 15, 2016
‌ US Patent 9278131 Process for lowering the viscosity of highly concentrated protein solutions	Patent 9278131 was granted and assigned to Adocia on March, 2016 by the United States Patent and Trademark Office.	Adocia	Adocia	United States Patent and Trademark Office	9278131	March 8, 2016
‌ US Patent 9493583 Anionic polysaccharides functionalized by a hydrophobic acid derivative	Patent 9493583 was granted and assigned to Adocia on November, 2016 by the United States Patent and Trademark Office.		Adocia	United States Patent and Trademark Office	9493583	November 15, 2016
‌ US Patent 10646551 Rapid-acting insulin formulation comprising a substituted anionic compound	Patent 10646551 was granted and assigned to Adocia on May, 2020 by the United States Patent and Trademark Office.	Adocia	Adocia	United States Patent and Trademark Office	10646551	May 12, 2020
‌ US Patent 9018190 Functionalized oligosaccharides	Patent 9018190 was granted and assigned to Adocia on April, 2015 by the United States Patent and Trademark Office.		Adocia	United States Patent and Trademark Office	9018190	April 28, 2015
‌ US Patent 8426382 Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative	Patent 8426382 was granted and assigned to Adocia on April, 2013 by the United States Patent and Trademark Office.		Adocia	United States Patent and Trademark Office	8426382	April 23, 2013
‌ US Patent 9795678 Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound	Patent 9795678 was granted and assigned to Adocia on October, 2017 by the United States Patent and Trademark Office.	Adocia	Adocia	United States Patent and Trademark Office	9795678	October 24, 2017
‌ US Patent 10987426 Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid	Patent 10987426 was granted and assigned to Adocia on April, 2021 by the United States Patent and Trademark Office.	Adocia	Adocia	United States Patent and Trademark Office	10987426	April 27, 2021
‌ US Patent 8629124 Dextran functionalized by hydrophobic amino acids	Patent 8629124 was granted and assigned to Adocia on January, 2014 by the United States Patent and Trademark Office.		Adocia	United States Patent and Trademark Office	8629124	January 14, 2014
‌ US Patent 10463717 Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog, and a co-polyamino acid	Patent 10463717 was granted and assigned to Adocia on November, 2019 by the United States Patent and Trademark Office.	Adocia	Adocia	United States Patent and Trademark Office	10463717	November 5, 2019
‌ US Patent 11065305 Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial action	Patent 11065305 was granted and assigned to Adocia on July, 2021 by the United States Patent and Trademark Office.	Adocia	Adocia	United States Patent and Trademark Office	11065305	July 20, 2021
‌ US Patent 10449256 Injectable solution at pH 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer	Patent 10449256 was granted and assigned to Adocia on October, 2019 by the United States Patent and Trademark Office.	Adocia	Adocia	United States Patent and Trademark Office	10449256	October 22, 2019
‌ US Patent 8389661 Complexes between an amphiphilic polymer and an osteogenic protein belonging to the family of BMPs	Patent 8389661 was granted and assigned to Adocia on March, 2013 by the United States Patent and Trademark Office.		Adocia	United States Patent and Trademark Office	8389661	March 5, 2013
‌ US Patent 10383920 Injectable solution at pH 7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals	Patent 10383920 was granted and assigned to Adocia on August, 2019 by the United States Patent and Trademark Office.	Adocia	Adocia	United States Patent and Trademark Office	10383920	August 20, 2019
‌ US Patent 10383918 Compositions in the form of an injectable aqueous solution comprising human glucagon and a statistical co-polyamino acid	Patent 10383918 was granted and assigned to Adocia on August, 2019 by the United States Patent and Trademark Office.	Adocia	Adocia	United States Patent and Trademark Office	10383918	August 20, 2019

Results per page:

38 results

0 selected

38 results

0 selected